Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Cherwell Laboratories
Cherwell Laboratories
Activities:
Analysis
X
LinkedIn
Trending Articles
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Fasenra for EGPA: addressing unmet needs
Benralizumab could offer patients with EGPA more treatment options, while reducing dependency on oral corticosteroids
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Bristol Myers Squibb and Cellares partner to expand CAR-T manufacturing capabilities
Cellares will optimise and automate select Bristol Myers Squibb CAR-T cell therapies onto its high-throughput manufacturing program, the Cell Shuttle
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Cherwell demonstrates distributor support capabilities at LabDays 2024
Prepared microbiological media product insight to be shared on Dorte Egelund’s stand by Cherwell experts at LabDays Stockholm 2024
Manufacturing
Cherwell launches Redipor Beta Bags to support continuous manufacturing of sterile medicinal products
New multiple-use sterile media transfer bags reduce time and risk during product transfer
Manufacturing
Cherwell joins the AnalytiChem group of companies
Leveraging collaboration opportunities to continue to deliver ultra-high-quality products and services while achieving growth ambitions
Infection Control
Cherwell welcomes new recruits as pharma environmental monitoring needs grow
Autumn 2023 sees five new starters across Cherwell’s expanding business to support continuing business growth in cleanroom microbiology
Sustainability
Cherwell to lead discussion on environmental monitoring and Annex 1
The annual event to be held at the Nottingham Belfry, 30 November – 1 December, will focus on the ongoing challenges of microbiological contamination control compliance
Training & Education
Cherwell launches EM and aseptic processes educational video hub
Delivering Knowledge training video library designed to educate individuals in the pharmaceutical and healthcare industries
Manufacturing
Cherwell plays a part in COVID-19 vaccine manufacturing programme
Largest ever single order for microbial air samplers for environmental monitoring of Grade A vaccine manufacturing facilities delivered
Subscribe now